Table of contents

Key facts

Active substance
Human monoclonal antibody targeting Staphylococcus aureus alpha-toxin (tosatoxumab)
Therapeutic area
  • Infectious diseases
  • Pneumology-allergology
Decision number
PIP number
Pharmaceutical form(s)
Solution for infusion
Condition(s) / indication(s)
Treatment of Staphylococcus aureus pneumonia
Route(s) of administration
Intravenous use
Contact for public enquiries
Aridis Pharmaceuticals Inc

Email: mmscltd@gmail.com    
Tel. +1 9252003089

Decision type
P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)


How useful was this page?

Add your rating